22.418 articles found

Adipose tissue derived stromal cells for the treatment of neurological disorders

WILKISON WILLIAM O, GIMBLE JEFFREY M, VANGURI PADMAVATHY.

· 2005-11-23

Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia.

Gao XM, Cooper T, Suckow RF, Tamminga CA.

Neuropsychopharmacology · 2005-11-23

DOI: 10.1038/sj.npp.1300975PMID: 16319911

Pharmaceutical compositions and uses comprising mucuna pruriens seed powder and extracts thereof in the treatment of neurological diseases

VAN DER GIESSEN ROB, OLANOW C W, LEES ANDREW, WAGNER HILDEBERT, OLANOW C. WARREN.

· 2005-11-18

Aminoadamantane derivatives as therapeutic agents

WANG YUQIANG, YE WENQING, LARRICK JAMES W, STAMLER JONATHAN S, LIPTON STUART A, STEMLER JONATHAN S.

· 2005-11-17

Aminoadamantane derivatives as therapeutic agents

WANG YUQIANG, YE WENQING, LARRICK JAMES W, STAMLER JONATHAN S, LIPTON STUART A, STEMLER JONATHAN S.

· 2005-11-17

SYSTEMS AND METHODS FOR SELECTING STIMULATION SITES AND APPLYING TREATMENT, INCLUDING TREATMENT OF SYMPTOMS OF PARKINSON'S DISEASE, OTHER MOVEMENT DISORDERS, AND/OR DRUG SIDE EFFECTS

WYLER Allen, FOWLER Brad.

· 2005-11-10

Follow-up of patients affected by manganese-induced Parkinsonism after treatment with CaNa2EDTA.

Herrero Hernandez E, Discalzi G, Valentini C, Venturi F, Chiò A, Carmellino C, Rossi L, Sacchetti A, Pira E.

Neurotoxicology · 2005-11-04

DOI: 10.1016/j.neuro.2005.09.003PMID: 16271769

Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.

Asai H, Udaka F, Hirano M, Minami T, Oda M, Kubori T, Nishinaka K, Kameyama M, Ueno S.

Parkinsonism Relat Disord · 2005-11-02

DOI: 10.1016/j.parkreldis.2005.06.007PMID: 16263322

Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.

Lee WY, Lee EA, Jeon MY, Kang HY, Park YG.

Exp Neurol · 2005-11-02

DOI: 10.1016/j.expneurol.2005.09.012PMID: 16269145

Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech.

Pinto S, Gentil M, Krack P, Sauleau P, Fraix V, Benabid AL, Pollak P.

Mov Disord · 2005-11-01

DOI: 10.1002/mds.20601PMID: 16037917

Stem cell therapy for human brain disorders.

Lindvall O, Kokaia Z.

Kidney Int · 2005-11-01

DOI: 10.1111/j.1523-1755.2005.00623.xPMID: 16221169

Present and future drug treatment for Parkinson's disease.

Schapira AH.

J Neurol Neurosurg Psychiatry · 2005-11-01

DOI: 10.1136/jnnp.2004.035980PMID: 16227533